This was the dosage regime for pediatric P3 aGVHD trial
"Subjects will be treated with intravenous (IV) remestemcel-L at a dose of 2 x 10e6 MSC/kg (actual body weight at screening) twice per week for each of 4 consecutive weeks."
So you yes 8 versus 2 doses, not sure of number of cells/kg rate though. I haven't been able to find the CTSN/NIH trial yet, maybe I'm using wrong search terms?
VILI and MSCs, page-13
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.025(2.55%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 99.0¢ | $3.029M | 3.018M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 104 | 208506 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 71938 | 21 |
View Market Depth
| Last trade - 13.35pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |